About General Hospital Sibenik
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at General Hospital Sibenik
During the past decade, General Hospital Sibenik conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis
2008-07-17
2023-12-16
Active, not recruiting
220
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
2011-03-02
2022-12-31
Completed
735
A Study of Atezolizumab in Combination With Carboplatin or Cisplatin + Pemetrexed Compared With Carboplatin or Cisplatin + Pemetrexed in Participants Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower 132)
2016-04-30
2022-12-13
Completed
578
A Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD).
2016-03-22
2019-05-31
Terminated
813
A Study of Tiragolumab in Combination With Atezolizumab in Chemotherapy-Naïve Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
2018-08-10
2024-03-31
Active, not recruiting
135
Non-interventional Study of Ocrelizumab in Participants With Relapsing or Primary Progressive Multiple Sclerosis
2018-11-12
2025-07-26
Active, not recruiting
1,700
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)
2020-11-26
2029-03-30
Recruiting
865
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
2020-10-26
2026-12-18
Recruiting
946
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "General Hospital Sibenik" #1 sponsor was "Kartos Therapeutics, Inc." with 1 trials, followed by "Mylan Pharmaceuticals Inc" with 1 trials
sponsored, "Pfizer" with 1 trials sponsored, "Pharming Technologies B.V." with 1 trials sponsored and "Takeda"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "General Hospital Sibenik"
#1 collaborator was "Hospira, now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at General Hospital Sibenik
According to Clinical.Site data, the most researched conditions in "General Hospital Sibenik" are
"Hereditary Angioedema" (2 trials), "Lactation" (1 trials), "NSCLC Stage IV" (1 trials), "Post-Essential Thrombocythemia MF (Post-ET-MF)" (1 trials) and "Post-Polycythemia Vera MF (Post-PV-MF)" (1 trials). Many other conditions were trialed in "General Hospital Sibenik" in a lesser frequency.
Clinical Trials Intervention Types at General Hospital Sibenik
Most popular intervention types in "General Hospital Sibenik" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Best Available Therapy (BAT)" (1 trials), "Bevacizumab as Avastin" (1 trials), "Bevacizumab as MYL-1402O" (1 trials), "KRT-232" (1 trials) and "rhC1INH or pdC1INH" (1 trials). Other intervention names were less common.
Clinical Trials Genders at General Hospital Sibenik
The vast majority of trials in "General Hospital Sibenik" are
5 trials for "All" genders.
Clinical Trials Status at General Hospital Sibenik
Currently, there are NaN active trials in "General Hospital Sibenik".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in General Hospital Sibenik,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in General Hospital Sibenik, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".